NCT04918797View on ClinicalTrials.gov

COVAXIN in a Pediatric Cohort

PHASE2/PHASE3CompletedINTERVENTIONAL
Enrollment

525

Participants

Timeline

Start Date

May 26, 2021

Primary Completion Date

August 15, 2021

Study Completion Date

January 25, 2022

Conditions
SARS-CoV2 Infection
Interventions
BIOLOGICAL

COVAXIN

Whole-Virion Inactivated SARS-CoV-2 Vaccine (COVAXIN®)

Trial Locations (7)

208002

Prakhar Hospital, Kanpur

305001

Jawahar Lal Nehru Medical college, Ajmer

440010

Meditrina Institute of Medical Sciences, Nagpur

500050

Pranam Hospitals Hyderabad, Hyderabad

530001

Victoria Government Hospital, Visakhapatnam

570001

Cheluvambha Hospital, Mysore

801507

All India Institute of Medical Sciences, Patna

All Listed Sponsors
lead

Bharat Biotech International Limited

INDUSTRY